GLOBAL SURGICAL SUTURES MARKET 2022-2028
MARKET OUTLOOK
Triton Market Research’s report puts forth that the global surgical sutures market is expected to register growth at a CAGR of 5.74% during the forecasted phase 2022-2028.
The increasing number of surgeries and enhanced availability of surgical sutures are the prime factors driving the growth of the market. In addition to this, the rising demand for minimally invasive surgeries is also contributing to the surgical sutures market’s growth. On the other hand, the availability of alternate wound care treatments is hindering this growth process. However, the emergence of nanofiber yarn-based sutures, preference for stitchless sutures over conventional sutures, and the rising development of smart sutures are creating lucrative opportunities for development.
REGIONAL OUTLOOK
The global market for surgical sutures covers the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.
North America is the largest market for surgical sutures globally, and is expected to continue its lead in the forthcoming years. According to industry sources, every year, an estimated 48.3 million surgical and non-surgical procedures are performed in the United States. The growth in such procedures is contributing to the development of the surgical sutures market in the region. Moreover, it is also home to companies operating in this field. The presence of such key players in North America has strengthened the growth of the surgical sutures market in North America.
COMPETITIVE OUTLOOK
The noteworthy players profiled in the report on the surgical sutures market include Internacional Farmaceutica SA De CV, Conmed Corporation, Lotus Surgicals, Zimmer Biomet Holdings Inc, Unisur Lifecare Pvt Ltd, Ethicon Inc (Johnson & Johnson), Demetech Corporation, Advanced Medical Solutions Group Plc (AMS Group), Boston Scientific Corporation, Stryker Corporation, B Braun Melsungen AG, Medtronic Plc, Smith & Nephew Plc, Corza Medical, and Teleflex Incorporated.
Boston Scientific Corporation is a company manufacturing medical devices used in interventional medical specialties. It offers suturing materials such as Fixate™ tissue band and Capio™ SLIM suture capturing device. Boston Scientific has a robust research and development network, which differentiates it from its competitors. In 2020, the company spent $1.14 billion on R&D. It operates in North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa. The company sells its products to over 35,000 hospitals, clinics, medical offices, and outpatient facilities in 130 countries. Boston Scientific was founded in 1979, and has a strong workforce of 38,000 employees.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook